Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase III Study: Supplemental Parenteral Nutrition for Patients With Locally Advanced Inoperable Tumors of the Head and Neck, Receiving Definitive Radiotherapy With Cetuximab or Cisplatin

NCT02236936 is registered in ClinicalTrials.gov with Arbeitsgemeinschaft medikamentoese Tumortherapie as lead sponsor.

NCT NCT02236936
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02236936 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase III Study: Supplemental Parenteral Nutrition for Patients With Locally Advanced Inoperable Tumors of the Head and Neck, Receiving Definitive Radiotherapy With Cetuximab or Cisplatin
Lead sponsor
Arbeitsgemeinschaft medikamentoese Tumortherapie
Phase
Phase 3
Overall status
Terminated
Start date
February 3, 2017
Completion date
July 10, 2019
Enrollment
8 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

laryngeal squamous cell carcinoma stage iii, laryngeal squamous cell carcinoma stage iv, locally advanced malignant neoplasm, oropharyngeal squamous cell carcinoma stage iii, oropharyngeal squamous cell carcinoma stage iv, squamous cell carcinoma of the hypopharynx stage iii, squamous cell carcinoma of the hypopharynx stage iv, squamous cell carcinoma of the oral cavity stage iii, squamous cell carcinoma of the oral cavity stage iv